285 related articles for article (PubMed ID: 11204567)
1. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro.
Nishiyama U; Morita H; Torii Y; Kuwaki T; Shimizu E; Akahori H; Kato T; Miyazaki H
Thromb Haemost; 2001 Jan; 85(1):152-9. PubMed ID: 11204567
[TBL] [Abstract][Full Text] [Related]
2. Defective c-Mpl signaling in the syndrome of thrombocytopenia with absent radii.
Ballmaier M; Schulze H; Cremer M; Folman CC; Strauss G; Welte K
Stem Cells; 1998; 16 Suppl 2():177-84. PubMed ID: 11012189
[TBL] [Abstract][Full Text] [Related]
3. A novel thrombopoietin signaling defect in polycythemia vera platelets.
Moliterno AR; Siebel KE; Sun AY; Hankins WD; Spivak JL
Stem Cells; 1998; 16 Suppl 2():185-92. PubMed ID: 11012190
[TBL] [Abstract][Full Text] [Related]
4. Thrombopoietin in vitro and in vivo.
Alexander WS; Begley CG
Cytokines Cell Mol Ther; 1998 Mar; 4(1):25-34. PubMed ID: 9557214
[TBL] [Abstract][Full Text] [Related]
5. The platelet thrombopoietin receptor number and function are markedly decreased in patients with essential thrombocythaemia.
Li J; Xia Y; Kuter DJ
Br J Haematol; 2000 Dec; 111(3):943-53. PubMed ID: 11122159
[TBL] [Abstract][Full Text] [Related]
6. The effect of MGDF on platelet function and thrombosis in animal models.
Toombs CF
Stem Cells; 1998; 16 Suppl 2():121-6. PubMed ID: 11012184
[TBL] [Abstract][Full Text] [Related]
7. The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis.
Nogami W; Yoshida H; Koizumi K; Yamada H; Abe K; Arimura A; Yamane N; Takahashi K; Yamane A; Oda A; Tanaka Y; Takemoto H; Ohnishi Y; Ikeda Y; Miyakawa Y
Haematologica; 2008 Oct; 93(10):1495-504. PubMed ID: 18728031
[TBL] [Abstract][Full Text] [Related]
8. IL-3 does not contribute to platelet production in c-Mpl-deficient mice.
Chen Q; Solar G; Eaton DL; de Sauvage FJ
Stem Cells; 1998; 16 Suppl 2():31-6. PubMed ID: 11012175
[TBL] [Abstract][Full Text] [Related]
9. Thrombocytopenia in HIV infection: impairment of platelet formation and loss correlates with increased c-Mpl and ligand thrombopoietin expression.
Sundell IB; Koka PS
Curr HIV Res; 2006 Jan; 4(1):107-16. PubMed ID: 16454716
[TBL] [Abstract][Full Text] [Related]
10. Thrombopoietin and its receptor.
Wendling F; Vainchenker W
Eur Cytokine Netw; 1998 Sep; 9(3):221-31. PubMed ID: 9831170
[TBL] [Abstract][Full Text] [Related]
11. [Congenital amegakaryocytic thrombocytopenia (CAMT) - a defect of the thrombopoietin receptor c-Mpl].
Germeshausen M; Schulze H; Gaudig A; Krukemeier S; Strauss G; Welte K; Ballmaier M
Klin Padiatr; 2001; 213(4):155-61. PubMed ID: 11528548
[TBL] [Abstract][Full Text] [Related]
12. Regulation of platelet activation in vitro by the c-Mpl ligand, thrombopoietin.
Chen J; Herceg-Harjacek L; Groopman JE; Grabarek J
Blood; 1995 Dec; 86(11):4054-62. PubMed ID: 7492761
[TBL] [Abstract][Full Text] [Related]
13. Stem cell factor synergistically enhances thrombopoietin-induced STAT5 signaling in megakaryocyte progenitors through JAK2 and Src kinase.
Drayer AL; Boer AK; Los EL; Esselink MT; Vellenga E
Stem Cells; 2005 Feb; 23(2):240-51. PubMed ID: 15671147
[TBL] [Abstract][Full Text] [Related]
14. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?
Folman CC; Linthorst GE; van Mourik J; van Willigen G; de Jonge E; Levi M; de Haas M; von dem Borne AE
Thromb Haemost; 2000 Jun; 83(6):923-30. PubMed ID: 10896250
[TBL] [Abstract][Full Text] [Related]
15. Hematopoietic deficiencies in c-mpl and TPO knockout mice.
Murone M; Carpenter DA; de Sauvage FJ
Stem Cells; 1998; 16(1):1-6. PubMed ID: 9474742
[TBL] [Abstract][Full Text] [Related]
16. Differentiation induced by the c-Mpl cytokine receptor is blocked by mutant Shc adaptor protein.
Hill RJ; Zozulya S; Lu YL; Hollenbach PW; Joyce-Shaikh B; Bogenberger J; Gishizky ML
Cell Growth Differ; 1996 Sep; 7(9):1125-34. PubMed ID: 8877093
[TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin: biology and clinical potentials.
Miyazaki H; Kato T
Int J Hematol; 1999 Dec; 70(4):216-25. PubMed ID: 10643146
[TBL] [Abstract][Full Text] [Related]
18. c-mpl, the thrombopoietin receptor.
Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
[TBL] [Abstract][Full Text] [Related]
19. A single intravenous dose of murine megakaryocyte growth and development factor potently stimulates platelet production, challenging the necessity for daily administration.
Daw NC; Arnold JT; Abushullaih BA; Stenberg PE; White MM; Jayawardene D; Srivastava DK; Jackson CW
Blood; 1998 Jan; 91(2):466-74. PubMed ID: 9427699
[TBL] [Abstract][Full Text] [Related]
20. Dose-response effects of pegylated human megakaryocyte growth and development factor on platelet production and function in nonhuman primates.
Harker LA; Marzec UM; Hunt P; Kelly AB; Tomer A; Cheung E; Hanson SR; Stead RB
Blood; 1996 Jul; 88(2):511-21. PubMed ID: 8695799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
